Biointelect Pty, Ltd.
Biointelect is a leading strategic planning and commercialisation advisory firm for the life science sector based in Australia. Founded in 2012, it channels the vision of its co-founders Jennifer and Karl Herz to bring innovative science to market. The company offers bespoke consulting services and strategic insights across the entire life science ecosystem to accelerate healthcare innovation for patients. With a global perspective and extensive experience in biotechnology and pharmaceutical sectors, Biointelect helps clients develop and execute strategies for new therapies, navigate regulatory pathways, and achieve successful market entry.
Industries
Nr. of Employees
small (1-50)
Biointelect Pty, Ltd.
Brookvale, New South Wales, Australia, Oceania
Products
Virtual incubator for vaccine and infectious disease innovations (Venturer)
A nation-wide virtual incubator designed to support SME-led early-stage vaccine, vaccine-related and infectious disease immunotherapy innovations to become investment-ready and commercialised locally.
Virtual incubator for vaccine and infectious disease innovations (Venturer)
A nation-wide virtual incubator designed to support SME-led early-stage vaccine, vaccine-related and infectious disease immunotherapy innovations to become investment-ready and commercialised locally.
Services
Research & Development Strategy and Planning
Consulting for R&D roadmaps, target product profiles, portfolio prioritisation, market analysis and grant/business case preparation.
Clinical Research Services
Protocol design, trial execution support, site start-up and full-service clinical research capabilities in partnership with clinical operations providers.
Regulatory Strategy
Regulatory classification, gap analysis, submission roadmaps and preparation for regulator engagement across jurisdictions.
Commercialisation Strategy
Go-to-market strategy, partner identification, pricing and lifecycle management to prepare products for launch and scale.
Patient Access and Health Economics
HTA preparation, reimbursement strategy, economic assessments and pricing strategy to support funded access.
Government Services and Public Policy
Policy development, white papers, stakeholder workshops and public sector engagement to shape health system frameworks.
Research & Development Strategy and Planning
Consulting for R&D roadmaps, target product profiles, portfolio prioritisation, market analysis and grant/business case preparation.
Clinical Research Services
Protocol design, trial execution support, site start-up and full-service clinical research capabilities in partnership with clinical operations providers.
Regulatory Strategy
Regulatory classification, gap analysis, submission roadmaps and preparation for regulator engagement across jurisdictions.
Commercialisation Strategy
Go-to-market strategy, partner identification, pricing and lifecycle management to prepare products for launch and scale.
Patient Access and Health Economics
HTA preparation, reimbursement strategy, economic assessments and pricing strategy to support funded access.
Government Services and Public Policy
Policy development, white papers, stakeholder workshops and public sector engagement to shape health system frameworks.
Expertise Areas
- Commercialisation strategy
- Clinical trial management and operations
- Regulatory strategy and submissions
- Market access, HTA and health economics
Key Technologies
- Viral vector manufacturing
- Cell and gene therapy manufacturing
- Vaccine development
- Nanoparticle drug delivery